Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Caspofungin Acetate in Treating Children With Fever and Neutropenia
This study has been completed.
Study NCT00020527 Information provided by National Cancer Institute (NCI)
First Received: July 11, 2001 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fever, Sweats, and Hot Flashes
Infection
Kidney Cancer
Leukemia
Lymphoma
Neuroblastoma
Neutropenia
Sarcoma
Additional conditions recognized in this trial
Carcinoma, Renal Cell
Communicable Diseases
Fever
Hot Flashes
Kidney Neoplasms
More general conditions related to this trial
Adenocarcinoma
Agranulocytosis
Body Temperature Changes
Carcinoma
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Kidney Diseases
Leukocyte Disorders
Leukopenia
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Signs and Symptoms
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
caspofungin acetate
Additional drug interventions recognized in this trial
Caspofungin
Echinocandins
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
